Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Paragraph 8 Sgb V On The Active Ingredient Vedolizumab, Atc L04ag05 For The Time 01.07.2025 30.2027 2025-11-20
Germany Open House Pharmaceutical Dact Treaties For The Active Ingredient Denosumab, Trade Name Xgeva, Atc M05bx04 2025-11-20
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lanreotide, Atc H01cb03 For The Time 01.07.2025 30.06.2026 (plus Extension Option 1x 12 Months) 2025-11-21
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Fusidic Acid, Atc D06ax01 For The Time 01.07.2025 30.06.2027 (plus Extension Option 1x12 Months) 2025-11-21
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Somatropin, Atc H01ac01 For The Time 01.07.2025 30.06.2027 2025-11-21
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Cabotegravir, Atc J05aj04 For The Time 01.07.2025 30.06.2027 2025-11-21
United Kingdom Supply Of Agency Workers For Care & Support Schemes 2025-11-21
India Procurement Of Reagents Of Eschweiler Micromed Electrolyte Analyzer For Dept. Of Pathology In Ddu Hospital On Pac Basis, New Born Gel Cards. 2025-11-22
Germany Delivery Of Hospital Beds And Bedside Tables For The Zsg And The Somatics public Tender 2025-11-22
United Kingdom Non Clinical Staffing 2 2025-11-22
Whats app